These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
826 related items for PubMed ID: 15890193
1. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor. Dunlop TW, Väisänen S, Frank C, Molnár F, Sinkkonen L, Carlberg C. J Mol Biol; 2005 Jun 03; 349(2):248-60. PubMed ID: 15890193 [Abstract] [Full Text] [Related]
2. Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter. Sinkkonen L, Malinen M, Saavalainen K, Väisänen S, Carlberg C. Nucleic Acids Res; 2005 Jun 03; 33(8):2440-51. PubMed ID: 15863722 [Abstract] [Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. Kim S, Shevde NK, Pike JW. J Bone Miner Res; 2005 Feb 03; 20(2):305-17. PubMed ID: 15647825 [Abstract] [Full Text] [Related]
4. Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-Dihydroxyvitamin D3. Väisänen S, Dunlop TW, Sinkkonen L, Frank C, Carlberg C. J Mol Biol; 2005 Jul 01; 350(1):65-77. PubMed ID: 15919092 [Abstract] [Full Text] [Related]
11. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor. Okano T, Nakagawa K, Tsugawa N, Ozono K, Kubodera N, Osawa A, Terada M, Mikami K. Biol Pharm Bull; 1998 Dec 01; 21(12):1300-5. PubMed ID: 9881643 [Abstract] [Full Text] [Related]
12. The 3-epi- and 24-oxo-derivatives of 1alpha,25 dihydroxyvitamin D(3) stimulate transcription through the vitamin D receptor. Messerlian S, Gao X, St-Arnaud R. J Steroid Biochem Mol Biol; 2000 Dec 01; 72(1-2):29-34. PubMed ID: 10731635 [Abstract] [Full Text] [Related]
13. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice. Chow EC, Quach HP, Vieth R, Pang KS. Am J Physiol Endocrinol Metab; 2013 May 01; 304(9):E977-89. PubMed ID: 23482451 [Abstract] [Full Text] [Related]
14. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK. J Endocrinol; 1997 Sep 01; 154 Suppl():S57-73. PubMed ID: 9379138 [Abstract] [Full Text] [Related]
15. VDR primary targets by genome-wide transcriptional profiling. Goeman F, De Nicola F, D'Onorio De Meo P, Pallocca M, Elmi B, Castrignanò T, Pesole G, Strano S, Blandino G, Fanciulli M, Muti P. J Steroid Biochem Mol Biol; 2014 Sep 01; 143():348-56. PubMed ID: 24726990 [Abstract] [Full Text] [Related]
17. Anti-proliferative activity of 25-hydroxyvitamin D3 in human prostate cells. Munetsuna E, Kawanami R, Nishikawa M, Ikeda S, Nakabayashi S, Yasuda K, Ohta M, Kamakura M, Ikushiro S, Sakaki T. Mol Cell Endocrinol; 2014 Feb 15; 382(2):960-70. PubMed ID: 24291609 [Abstract] [Full Text] [Related]